ArticleMolecular medicine (Cambridge, Mass.)2025

NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma.

Chao-Yan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.